Arthritis & Rheumatology (Hoboken, N.j.) | 2021
COVID‐19 Reinfection in a Patient Receiving Immunosuppression for ANCA‐associated Vasculitis
Abstract
Abstract A 61‐year‐old South Asian woman presented in early April 2020, during the first peak of the COVID‐19 pandemic, with acute onset dry cough, dyspnea, fever, and myalgia. Initial laboratory tests were suggestive of COVID‐19 (neutrophil:lymphocyte ratio 10.3, platelets 517x109/L, CRP 236mg/L, D‐dimer 5794µg/L, ferritin 528µg/L, troponin 881ng/L), and infection was confirmed by SARS‐CoV‐2 PCR testing of a nasopharyngeal swab. She received supportive care for COVID‐19 and had gradual resolution of fever and myalgia over the following 14 days.